Since DDX5 knockout in HCC cells leads to persistent activation of Wnt/β-catenin signaling [7], herein, our investigations focused on the impact of Wnt/β-catenin activation in HCC progression and treatment outcomes. This evidence concerns the gene DDX5 and hepatocellular carcinoma.